3D modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model.
Wai, Patty T
AffiliationThe Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer, The Institute of Cancer Research, London
MetadataShow full item record
AbstractThe initiation and progression of breast cancer from the transformation of the normal epithelium to ductal carcinoma in situ (DCIS) and invasive disease is a complex process involving the acquisition of genetic alterations, changes in gene expression, alongside microenvironmental and recognised histological alterations. Here we sought to comprehensively characterise the genomic and transcriptomic features of the MCF10 isogenic model of breast cancer progression and to functionally validate potential driver alterations in 3-dimensional (3D) spheroids that may give insight into breast cancer progression and identify targetable alterations in conditions more similar to those encountered in vivo. We performed whole genome, exome and RNA sequencing of the MCF10 progression series to catalogue the copy number, mutational and transcriptomic landscapes associated with progression. We identified a number of predicted driver mutations (including PIK3CA and TP53) that were acquired from non-malignant MCF10A cells to their malignant counterparts that are also present in primary breast cancers re-analysed from The Cancer Genome Atlas (TCGA). Acquisition of genomic alterations identified MYC amplification and previously un-described RAB3GAP1-HRAS and UBA2-PDCD2L expressed in-frame fusion genes in malignant cells. Comparison of pathway aberrations associated with progression identified that when cells are grown as 3D spheroids, they show perturbations of cancer-relevant pathways. Functional interrogation of the dependency on predicted driver events, identified alterations in HRAS, PIK3CA, and TP53 that selectively decreased cell growth and were associated with progression from pre-invasive to invasive disease, only when cells were grown as spheroids. Our results have identified changes in the genomic repertoire in cell lines representative of the stages of breast cancer progression and demonstrate that genetic dependencies can be uncovered when cells are grown in conditions more like in vivo. The MCF10 progression series, therefore, represents a good model to dissect potential biomarkers and evaluation of therapeutic targets involved in the progression of breast cancer.
Citation3D modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model. 2016: J. Pathol.
JournalThe Journal of Pathology
- Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection.
- Authors: Hernandez L, Wilkerson PM, Lambros MB, Campion-Flora A, Rodrigues DN, Gauthier A, Cabral C, Pawar V, Mackay A, A'Hern R, Marchiò C, Palacios J, Natrajan R, Weigelt B, Reis-Filho JS
- Issue date: 2012 May
- High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model.
- Authors: Worsham MJ, Pals G, Schouten JP, Miller F, Tiwari N, van Spaendonk R, Wolman SR
- Issue date: 2006 Mar
- Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma <i>In Situ</i> to Invasive Ductal Carcinoma.
- Authors: Pareja F, Brown DN, Lee JY, Da Cruz Paula A, Selenica P, Bi R, Geyer FC, Gazzo A, da Silva EM, Vahdatinia M, Stylianou AA, Ferrando L, Wen HY, Hicks JB, Weigelt B, Reis-Filho JS
- Issue date: 2020 Jul 15
- Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.
- Authors: Pang JB, Savas P, Fellowes AP, Mir Arnau G, Kader T, Vedururu R, Hewitt C, Takano EA, Byrne DJ, Choong DY, Millar EK, Lee CS, O'Toole SA, Lakhani SR, Cummings MC, Mann GB, Campbell IG, Dobrovic A, Loi S, Gorringe KL, Fox SB
- Issue date: 2017 Jul
- Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer.
- Authors: Bergholtz H, Kumar S, Wärnberg F, Lüders T, Kristensen V, Sørlie T
- Issue date: 2020 Jun